Oraya Therapeutics wins award for eye drug delivery system; Gold nanoparticle breakthrough published;

> Fierce 15 company Oraya Therapeutics won silver at the Annual Medical Design Excellence Awards for its IRay Radiotherapy System to treat wet age-related macular degeneration. The device reduces or sometimes eliminates the need for injections of anti-VEGF (vascular endothelial growth factor) medication. More

> German academics have published the results of their study of drug-delivering gold nanoparticles in Nature Nanotechnology. "Our results show that even nanoparticle-conjugates that appear highly stable can change their properties when deployed in the human body," said lead researcher Dr. Wolfgang Kreyling. "The study will thus have an influence on future medical applications as well as on the risk evaluation of nanoparticles in consumer products and in science and technology." More

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.